Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products — Content and Format
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 12, 2011
February 4, 2025
568083e9-c4f3-4df6-8658-e5f4d5f903c0
Related Documents
Providing Regulatory Submissions in Electronic Format--Receipt Date: Guidance for Industry
Guidance DocumentFebruary 10, 2014Center for Drug Evaluation and Research
Medication Guides — Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)
Guidance DocumentNovember 18, 2011Center for Drug Evaluation and Research
Labeling for Human Prescription Drug and Biological Products - Implementing the PLR Content and Format Requirements
Guidance DocumentFebruary 25, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.